Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →
logo
Get CLEATUS

Kidney Cancer Clinical Research Execution

Active
Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract titled Kidney Cancer Clinical Research Execution aims to advance clinical and translational research focused on kidney cancer through comprehensive scientific activities including study design, patient data collection, biomarker analysis, and therapeutic development. The work is intended to support the development of innovative treatments and diagnostic strategies by integrating clinical observations with laboratory research, ensuring findings are rapidly translated into improved patient outcomes. The project requires expertise in oncology research methodologies, rigorous data management, and interdisciplinary collaboration to address critical gaps in kidney cancer understanding and care. This subcontract is issued by the Defense Health Agency Contracting Activity under the Department of Defense and falls under NAICS code 541711, indicating it is related to research and development in the life sciences. The opportunity was posted on June 18, 2026, with a response deadline of September 28, 2026, providing potential applicants approximately three months to prepare and submit proposals. The place of performance and specific office address details are not specified, suggesting flexibility in location but requiring proposers to align with the overarching objectives of the Department of Defense’s medical research priorities. All work must demonstrate scientific excellence, feasibility, and direct relevance to advancing kidney cancer therapeutics within a clinical context.

General Info

DoD funds kidney cancer research to advance therapeutics via clinical and translational science.

Agency

Department Of Defense → Defense Health Agency Contracting Activity - DhacaView Agency

NAICS

541711 - Research and Development in BiotechnologyView NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency Contracting Activity - Dhaca
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → Defense Health Agency Contracting Activity - Dhaca
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Conduct clinical or translational kidney cancer research including study design, patient data collection, biomarker analysis, and therapeutic development.

Similar Contracts

Same NAICS industry code

NAICS: 541711
New
Federal
In Vitro ADMET AssaysThe contract titled In Vitro ADMET Assays calls for the performance of high-throughput in vitro screening focused on metabolic stability, hepatotoxicity, CYP450 enzyme interactions, and cellular permeability to support early-stage drug development. These assays are critical for evaluating the absorption, distribution, metabolism, excretion, and toxicity profiles of potential therapeutic candidates, enabling informed decisions before advancing compounds into costly clinical stages. The work will be conducted to meet the specific needs of the National Institutes of Health NIDA under the Department of Health and Human Services, with performance expected to occur in Bethesda. This is a subcontract opportunity under NAICS code 541711, which classifies it as research and development in the physical, engineering, and life sciences. The solicitation was posted on August 3, 2026, with a response deadline of August 18, 2026, at 7:00 PM Eastern Time. There is no set-aside classification specified, and no point of contact or detailed office address is provided in the data. Interested parties must submit their proposals before the deadline to be considered for award, with the expectation that the selected contractor will deliver reliable, scalable, and scientifically rigorous ADMET data to guide NIDA’s research initiatives in drug development.
National Institutes Of Health Nida

POSTED

3 days ago

DEADLINE

in 13 days
View Details
NAICS: 541711
New
Federal
Genotoxicity and Carcinogenicity TestingThe contract seeks to perform in vitro and in vivo assays to assess the mutagenic and carcinogenic risks of drug candidates, ensuring compliance with regulatory safety standards for pharmaceutical development. The work is critical for identifying potential genetic toxicity and cancer-causing properties early in the drug evaluation process to support regulatory submissions and public health safeguards. The solicitation is issued as a subcontract under the National Institutes of Health NIDA, part of the Department of Health and Human Services, with performance expected to take place in Bethesda. It falls under the NAICS code 541711 for research and development in the physical, engineering, and life sciences. The proposal must be submitted by August 18, 2026, with the opportunity posted on August 3, 2026. No set-aside provisions are specified, and the contract is open to qualified subcontractors with the technical capacity to deliver high-quality genotoxicity and carcinogenicity testing services.
National Institutes Of Health Nida

POSTED

3 days ago

DEADLINE

in 13 days
View Details
NAICS: 541711
New
Federal
Safety Pharmacology (CNS, Cardiovascular, Pulmonary)The contract requires comprehensive safety pharmacology studies to evaluate adverse effects on the central nervous system, cardiovascular system, and pulmonary function, ensuring alignment with ICH safety guidelines. The work will involve detailed pharmacodynamic assessments to identify and characterize potential risks to major organ systems during early drug development, with a focus on identifying safety signals that could impact clinical translation. This subcontract, issued by the National Institutes of Health’s NIDA under the Department of Health and Human Services, is set to be performed in Bethesda and has a response deadline of August 18, 2026. The effort is classified under NAICS code 541711, indicating it pertains to research and development in the life sciences, and is aimed at supporting regulatory-compliant preclinical safety evaluations essential for pharmaceutical advancement.
National Institutes Of Health Nida

POSTED

3 days ago

DEADLINE

in 13 days
View Details
NAICS: 541711
New
Federal
Toxicity Testing (Acute, Subacute, Subchronic, Chronic)The contract requires the performance of comprehensive toxicity testing in both rodent and non-rodent models to assess organ toxicity and establish safety margins for submission to regulatory authorities as part of an Investigational New Drug application. The scope includes acute, subacute, subchronic, and chronic studies designed to evaluate the potential adverse effects of pharmaceutical compounds across a range of exposure durations and dosages. The work must meet rigorous scientific standards to support regulatory filings and ensure the safety profile of investigational drugs is adequately characterized prior to human trials. This subcontract is issued under the National Institutes of Health, National Institute on Drug Abuse, within the Department of Health and Human Services, with the performance location specified as Bethesda. The North American Industry Classification System code 541711 identifies the work as research and development in the life sciences. The solicitation was posted on August 3, 2026, with a mandatory response deadline of August 18, 2026, at 7:00 PM. No set-aside provisions are specified, and the contract opportunity is open to eligible contractors capable of executing preclinical toxicology studies to support IND submissions.
National Institutes Of Health Nida

POSTED

3 days ago

DEADLINE

in 13 days
View Details
NAICS: 541711
New
Federal
In Vivo Pharmacokinetic StudiesThe contract seeks to perform in vivo pharmacokinetic studies to assess the absorption, distribution, metabolism, and excretion of a drug candidate in both rodent and non-rodent species across multiple administration routes, with the goal of generating data to support an Investigational New Drug application. These studies will evaluate drug exposure over time to establish pharmacokinetic profiles critical for regulatory submission, requiring rigorous experimental design, appropriate species selection, and adherence to good laboratory practices. All work must be completed to ensure high-quality, reproducible results that meet FDA expectations for preclinical development. The solicitation is classified as a subcontract under NAICS code 541711, issued by the National Institutes of Health through the National Institute on Drug Abuse, part of the Department of Health and Human Services. Performance is expected to take place in Bethesda, and interested parties must submit their responses no later than August 18, 2026, at 7:00 PM. The opportunity was posted on August 3, 2026, and is open for competitive bidding with no specific set-aside designation. The contract does not provide a point of contact, and all inquiries must be directed through the official SAM.gov portal linked in the posting.
National Institutes Of Health Nida

POSTED

3 days ago

DEADLINE

in 13 days
View Details
NAICS: 541711
New
Federal
Influenza Vaccine Clinical Trial ManagementThe contract pertains to the design and management of Phase I–III clinical trials for influenza vaccines, encompassing all critical aspects from protocol development and site selection to patient recruitment and regulatory reporting to the FDA. The work requires specialized expertise in infectious disease trials, with a focus on ensuring compliance with regulatory standards and timely submission of clinical data. The performance location is in Washington, DC, with a zip code of 20024, indicating the primary operational base for trial oversight and coordination. This is a subcontract under the Department of Health and Human Services, specifically managed by Barda – ASPR / DAAPPO / Barda DCMA, with a NAICS code of 541711 indicating scientific research and development services. The opportunity was posted on July 30, 2026, with a response deadline of August 15, 2026, at 9:00 PM ET. While no set-aside type or point of contact is specified, the emphasis on end-to-end clinical trial management suggests the subcontractor must possess a proven track record in vaccine development, regulatory engagement, and multi-site trial execution under federal health security initiatives.
Barda - Aspr / Daappo / Barda Dcma

POSTED

7 days ago

DEADLINE

in 10 days
View Details
NAICS: 541711
Federal
Clinical Trial Design and Efficacy Data GenerationThe contract calls for the design and execution of clinical trials aimed at evaluating the safety, wound closure, infection control, and functional regeneration outcomes of medical interventions in patients with burn and trauma injuries. The work requires rigorous scientific methodology to generate robust efficacy data that supports regulatory and clinical adoption, with a focus on measurable endpoints related to tissue recovery and patient outcomes. The trials must be conducted in accordance with established clinical standards and are intended to provide evidence of therapeutic effectiveness under real-world conditions. This is a subcontract under the Aspr Administration for Strategic Preparedness and Response, part of the Department of Health and Human Services, with a solicitation posted on July 28, 2026, and a response deadline of August 28, 2026. The work is classified under NAICS code 541711, indicating research and development in the life sciences. The performance location is designated with a zip code of 77416, though no specific city or state is provided, and no point of contact details are listed. The contract does not include a set-aside designation, and all eligible entities may respond, with emphasis placed on technical capability, trial design expertise, and experience in trauma and burn clinical research.
Aspr Administration For Strategic Preparedness And Response

POSTED

9 days ago

DEADLINE

in 23 days
View Details
NAICS: 541711
Federal
Induced Pluripotent Stem Cell (iPSC) Reprogramming ServicesThe contract entails the reprogramming of human articular chondrocytes and bone marrow cells into induced pluripotent stem cells using Sendai virus technology, with full support for culture expansion and cryopreservation of the resulting iPSCs. This subcontract is part of a research initiative led by the Department of Veterans Affairs through Rpo East, focused on advancing regenerative medicine techniques through advanced cellular reprogramming methods. The work requires precise adherence to protocols ensuring high efficiency, safety, and scalability of iPSC generation while maintaining cell viability and pluripotency throughout the process. The solicitation is open for responses until August 6, 2026, and falls under NAICS code 541711, indicating it is for research and development in the biological sciences. The agreement is structured as a subcontract, suggesting it will be awarded to a specialized contractor with expertise in stem cell biology and virology-based reprogramming. Performance is expected to meet rigorous quality standards for cellular products intended for potential therapeutic or diagnostic applications, with an emphasis on reproducibility and documentation. All deliverables must include verified iPSC lines archived through cryopreservation, ready for downstream use in future studies or clinical translation.
Rpo East (36C24E)

POSTED

14 days ago

DEADLINE

in about 13 hours
View Details
NAICS: 541711
Federal
Emerging Animal & Zoonotic Disease Diagnostics Research
Sci Technology Acq Division

POSTED

23 days ago

DEADLINE

in 9 days
View Details
NAICS: 541711
Grant
Preclinical Animal Studies for Neurofibromatosis ResearchThe contract seeks to conduct preclinical in vivo studies using genetically engineered mouse models or alternative animal models of neurofibromatosis to assess the efficacy of therapeutic interventions, track tumor progression, and investigate underlying biological mechanisms. The work requires advanced expertise in animal modeling, tumor biology, and preclinical drug evaluation, with a focus on generating robust, reproducible data to support future clinical translation. All studies must be conducted in accordance with established ethical and scientific standards for animal research, with detailed documentation of methodologies, outcomes, and adverse events. This subcontract is issued under the Defense Health Agency Contracting Activity and falls under NAICS code 541711, indicating it supports research and development in the physical, engineering, and life sciences. The solicitation was posted on June 25, 2026, with a response deadline of September 22, 2026, and is open to qualified entities capable of executing complex preclinical studies. While the place of performance and point of contact details are unspecified, successful proposers must demonstrate capacity to manage animal facilities, comply with regulatory requirements, and deliver high-quality, timely results in support of neurofibromatosis research objectives under the Department of Defense.
Defense Health Agency Contracting Activity - Dhaca

POSTED

about 1 month ago

DEADLINE

in about 2 months
View Details
NAICS: 541711
Grant
Collaborative Biomedical Research ExecutionThis contract enables a collaborative biomedical research effort focused on neurofibromatosis, requiring coordinated hypothesis-driven investigations led by an Initiating Principal Investigator and a Partnering Principal Investigator. The work encompasses the design of experiments, generation of empirical data, and rigorous milestone-based progress reporting to ensure scientific rigor and accountability. The project is structured as a subcontract under the Defense Health Agency Contracting Activity, falling under the NAICS code for research and development in the physical, engineering, and life sciences, and is intended to advance understanding of neurofibromatosis through integrated scientific contributions. The solicitation was posted on June 25, 2026, with a response deadline of September 22, 2026, and is managed by the Department of Defense through its health research infrastructure. While no set-aside provisions or specific location details are provided, the emphasis is firmly on outcome-driven research with clearly defined deliverables tied to research milestones. The effort requires close alignment between the two principal investigators to ensure cohesive experimental planning, data integrity, and timely reporting, reflecting a strategic investment in translational medical science with potential implications for defense-relevant health conditions.
Defense Health Agency Contracting Activity - Dhaca

POSTED

about 1 month ago

DEADLINE

in about 2 months
View Details
NAICS: 541711
Grant
Collaborative Research Partnership (Partnering PI Option)This contract establishes a collaborative research partnership where a Partnering Principal Investigator from an external institution will co-lead the research effort alongside the primary team, sharing equal responsibility for scientific direction, project management, and deliverables. Funding is jointly allocated between the participating institutions, ensuring aligned resources and mutual accountability for outcomes, with the work focused on health-related research under the Defense Health Agency Contracting Activity. The initiative falls under NAICS code 541711, indicating it is within the scientific research and development sector, and is structured as a subcontract to support integrated, multi-institutional innovation. The opportunity was posted on June 18, 2026, with a deadline for responses set for September 28, 2026, providing potential partners a defined window to submit proposals. The partnership is expected to be conducted in alignment with the mission of the Department of Defense, addressing critical health priorities through joint scientific leadership. There is no set-aside designation specified, meaning eligibility is open to qualified institutions regardless of size or status, and no specific location is designated for performance, allowing flexibility in where the research activities are carried out as long as the objectives are met collaboratively.
Defense Health Agency Contracting Activity - Dhaca

POSTED

about 2 months ago

DEADLINE

in about 2 months
View Details

More opportunities from Department Of Defense → Defense Health Agency Contracting Activity - Dhaca

Same awarding agency

NAICS: 541715
New
Grant
DoW Reconstructive Transplant, Investigator-Initiated Research AwardThe FY26 Reconstructive Transplant Research Program Investigator-Initiated Research Award supports innovative, scientifically rigorous studies aimed at advancing reconstructive transplant research and improving patient outcomes, particularly for military Service Members, Veterans, and their families. Proposals must demonstrate strong scientific rationale and direct military relevance, addressing healthcare needs arising from traumatic injuries, and are expected to contribute meaningfully to short- and long-term advances in the field. Eligible research spans the full spectrum from basic science and preclinical animal models to clinical studies involving human subjects or anatomical tissues, but explicitly excludes clinical trials as defined by federal guidelines. A robust study design with attention to reproducibility, including a statistically sound power analysis, is required to ensure the validity and translational potential of the proposed work. Applicants must include preliminary or published data that directly support the feasibility and relevance of the research to reconstructive transplantation, and projects must align with one or more of the designated FY26 RTRP Focus Areas. While collaboration with military researchers and clinicians is encouraged to enhance relevance and impact, it is not a mandatory requirement. The program is open to investigators across academic, medical, and research institutions who can demonstrate a clear pathway from laboratory findings to improved care and quality of life. Applications should emphasize the potential for broad impact both within the reconstructive transplant community and among the wider population of trauma survivors. All submissions must be made through the eBRAP system with inquiries directed to the designated point of contact.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

2 days ago

DEADLINE

N/A
View Details
NAICS: 541690
Grant
Scientific Peer Review and Grant Evaluation ServicesThe contract seeks qualified independent scientific reviewers to conduct peer evaluations of research proposals submitted to the Defense Health Agency under the Department of Defense's Congressional Directed Medical Research Programs. The review process must rigorously assess proposals based on five core criteria established by DoD/CDMRP standards: scientific significance, innovation, methodological approach, investigator qualifications, and the adequacy of the research environment. Reviewers are expected to deliver impartial, expert-level analyses that inform funding decisions and uphold the integrity of the military healthcare research portfolio. This engagement is structured as a subcontract under NAICS code 541690, with a response deadline of September 22, 2026, and is open to entities capable of supporting high-stakes, mission-critical scientific evaluation under federal oversight.
Other Scientific and Technical Consulting Services

POSTED

about 1 month ago

DEADLINE

in about 2 months
View Details
NAICS: 541611
Grant
Regulatory and Reporting Compliance SupportThe contract supports the preparation and submission of regulatory documentation required for federal research compliance, with specific attention to foreign affiliation disclosures, biosketches, and current and pending support forms. It mandates strict adherence to NSPM-33 guidelines and CDMRP requirements, ensuring that all submitted materials meet the Department of Defense’s standards for transparency, accountability, and conflict-of-interest management. This work is critical for maintaining eligibility for federal funding and ensuring alignment with national security and ethical research protocols. This is a subcontract awarded under the NAICS code 541611 for scientific research and development services, with a response deadline of September 22, 2026, and a posting date of June 25, 2026. The contracting activity is managed by the Defense Health Agency Contracting Activity under the Department of Defense, though specific performance location and point of contact details are not provided. All work is expected to be performed in compliance with federal regulations governing research integrity and external funding disclosures, and the subcontractor must possess expertise in navigating complex regulatory environments tied to defense-funded biomedical and health research initiatives.
Administrative Management and General Management Consulting Services

POSTED

about 1 month ago

DEADLINE

in about 2 months
View Details
NAICS: 541690
Grant
Scientific Data Management and FAIR Compliance SupportThe contract seeks support for scientific data management with a focus on achieving full compliance with FAIR principles—ensuring research outputs are Findable, Accessible, Interoperable, and Reusable. This includes comprehensive data curation, precise metadata tagging, and end-to-end repository management to enhance the quality, discoverability, and long-term utility of defense-related research data. The effort requires seamless integration with Department of Defense systems, particularly eBRAP, to synchronize data workflows and uphold institutional standards for documentation, access, and reporting. The work is structured as a subcontract under the Defense Health Agency Contracting Activity, classified under NAICS code 541690 for other scientific and technical consulting services. Proposals must be submitted by September 22, 2026, and performance is expected to support critical DoD research initiatives, with no geographic restrictions specified for the place of performance. The contract emphasizes technical rigor in data governance, alignment with federal data stewardship mandates, and the ability to operate within highly regulated defense environments to ensure compliance, security, and interoperability across systems.
Other Scientific and Technical Consulting Services

POSTED

about 1 month ago

DEADLINE

in about 2 months
View Details
NAICS: 541715
Grant
Neurofibromatosis Research Execution – Hypothesis-Driven Laboratory StudiesThe contract seeks to advance understanding of neurofibromatosis through innovative, hypothesis-driven laboratory research aimed at addressing high-impact scientific questions with the potential to reshape current paradigms in disease mechanisms or therapeutic approaches. The work requires rigorous experimental design, comprehensive data collection and analysis, and clear reporting of findings, all focused on generating transformative insights that could lead to novel treatments or diagnostic strategies. This subcontract is issued by the Defense Health Agency Contracting Activity under the Department of Defense and falls under NAICS code 541715 for research and development in the physical, engineering, and life sciences. Proposals must be submitted by September 22, 2026, with the research expected to be conducted at the performer’s facility, though the specific location is not designated. The initiative prioritizes originality and scientific impact over incremental progress, demanding a strong theoretical foundation and the potential to significantly alter the landscape of neurofibromatosis research.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 1 month ago

DEADLINE

in about 2 months
View Details
NAICS: 541618
Grant
Scientific Editing and Grant Writing SupportThe contract seeks qualified vendors to deliver professional editing, writing, and formatting services focused on technical reports, progress reviews, and scientific publications for the Defense Health Agency Contracting Activity. Services must meet high standards of clarity, accuracy, and compliance with federal and military documentation requirements, with an emphasis on technical and scientific content. The work is classified as a subcontract and falls under NAICS code 541618, which covers other scientific and technical consulting services. Respondents must submit proposals by the deadline of September 22, 2026, and the opportunity was posted on June 25, 2026. No specific location is designated for performance, and there is no set-aside designation, meaning all eligible entities may compete. The contract is managed under the Department of Defense and is accessible through the Grants.gov platform for full details and submission.
Other Management Consulting Services

POSTED

about 1 month ago

DEADLINE

in about 2 months
View Details
NAICS: 518210
Grant
Data Management and Sharing Plan DevelopmentThe contract requires the development and implementation of a compliant Data Management and Sharing Plan in accordance with NIH and Department of Defense requirements, focusing on establishing robust metadata standards, selecting appropriate data repositories, and defining strict access controls to ensure data integrity and regulatory adherence. The successful offeror must align all activities with federal guidelines to facilitate transparent, secure, and reusable data sharing practices across research initiatives funded by these organizations. Work under this subcontract must be completed by the September 22, 2026, deadline and will be performed under the auspices of the Defense Health Agency Contracting Activity within the Department of Defense. The NAICS code 518210 indicates this involves data processing, hosting, and related services, emphasizing technical expertise in compliant data infrastructure. There is no set-aside designation, and while specific performance location details are not provided, the effort is expected to support broader DoD and NIH research objectives through standardized, scalable, and auditable data management practices.
Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services

POSTED

about 1 month ago

DEADLINE

in about 2 months
View Details
NAICS: 541380
Grant
Molecular and Genomic Laboratory TestingThe contract seeks a subcontractor to conduct advanced molecular and genomic testing on tissue samples from individuals with neurofibromatosis, specifically focusing on next-generation sequencing, RNA sequencing, and other related molecular profiling techniques. The work aims to generate detailed genetic and transcriptomic data to enhance understanding of the disease’s molecular mechanisms, with the expectation that results will support clinical or research initiatives tied to defense health programs. All testing must adhere to high standards of accuracy, reproducibility, and data integrity, with samples received from designated sources and processed under protocols that ensure traceability and quality control. The opportunity is posted under NAICS code 541380, indicating it is classified as other scientific and technical consulting services, and is issued by the Defense Health Agency Contracting Activity under the Department of Defense. Interested parties must submit proposals by the deadline of September 22, 2026, and the work is expected to be performed domestically though the exact location is not specified. The contract does not include set-aside provisions for small businesses or other designated categories, and there is no designated point of contact listed in the posting. Proposals should demonstrate technical expertise in genomic analysis, experience with clinical or research-grade tissue samples, and the capacity to deliver actionable data within stringent timelines.
Testing Laboratories and Services

POSTED

about 1 month ago

DEADLINE

in about 2 months
View Details
NAICS: 541611
Grant
Clinical Trial Design and Biostatistical SupportThe contract seeks a subcontractor to provide comprehensive biostatistical consulting services in support of clinical and translational research initiatives, with a focus on study design, power analysis, randomization procedures, and the development of robust data analysis plans. The work is intended to ensure methodological rigor and statistical validity across defense-related health research projects, requiring expertise in applying statistical principles to real-world clinical trial scenarios. The contractor must be capable of tailoring statistical methodologies to the unique constraints and objectives of military and veteran health research environments. This opportunity is issued under the Defense Health Agency Contracting Activity, operating within the Department of Defense, and is classified under NAICS code 541611 for scientific research and development services. The solicitation was posted on June 25, 2026, with a response deadline of September 22, 2026. Performance location details are not specified, indicating potential flexibility in execution, though the work must align with the Agency’s operational and research priorities. As a subcontract, this engagement is likely part of a larger research initiative, and proposers should be prepared to collaborate effectively with primary contractors and federal research teams to deliver timely, high-quality statistical support.
Administrative Management and General Management Consulting Services

POSTED

about 1 month ago

DEADLINE

in about 2 months
View Details
NAICS: 541611
Grant
Foreign Affiliation and Conflict of Interest (COI) Disclosure ManagementThe contract focuses on supporting the identification, documentation, and timely disclosure of foreign affiliations and conflicts of interest among key personnel to ensure strict compliance with NSPM-33 and all applicable federal research security mandates. This effort is critical for safeguarding federally funded research integrity by mitigating risks associated with undue foreign influence and ensuring transparency in personnel relationships with foreign entities. The work requires thorough vetting of affiliations, accurate recordkeeping, and structured reporting processes aligned with government standards. The subcontract is issued by the Defense Health Agency Contracting Activity under the Department of Defense and is classified under NAICS code 541611, indicating it pertains to scientific research and development services. The opportunity was posted on June 25, 2026, with a response deadline set for September 22, 2026. The performance location is not specified, and no set-aside provisions or point of contact details are provided, but the scope demands specialized expertise in research compliance, institutional policy alignment, and federal security protocols for high-risk research environments.
Administrative Management and General Management Consulting Services

POSTED

about 1 month ago

DEADLINE

in about 2 months
View Details
NAICS: 541690
Grant
Scientific Writing and Proposal Coordination ServicesThe contract for Scientific Writing and Proposal Coordination Services requires the vendor to support the development and integration of critical proposal components including the Statement of Work, Impact Statement, Lay Abstract, and Transition Plan, ensuring all materials are clear, responsive, and aligned with grant application requirements. The work is focused on enhancing the quality and coherence of submissions to secure funding, with an emphasis on technical accuracy and strategic communication tailored to federal grant reviewers. This subcontract is issued under the NAICS code 541690 and is managed by the Defense Health Agency Contracting Activity within the Department of Defense. The opportunity was posted on June 25, 2026, with a deadline for responses set for September 22, 2026. No specific location is designated for performance, and there is no set-aside designation or point of contact provided. Interested parties must submit proposals through the Grants.gov portal using the provided UI link before the deadline.
Other Scientific and Technical Consulting Services

POSTED

about 1 month ago

DEADLINE

in about 2 months
View Details